MYL1
protein-codingmyosin light chain 1, the group of Myosin light chains, class 1
Gene summary
Myosin is a hexameric ATPase cellular motor protein. It is composed of two heavy chains, two nonphosphorylatable alkali light chains, and two phosphorylatable regulatory light chains. This gene encodes a myosin alkali light chain expressed in fast skeletal muscle. Two transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~25.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0034109
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0034109
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0034109
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0034109
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019952
Submitter: ClinGen
*MYL1* was reported in relation to autosomal recessive congenital myopathy in 2018 (Ravenscroft et al., PMID: 30215711). At least 2 unique variants (splicing, missense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 2 probands in 1 publication (PMID: 30215711). This gene-disease association is supported by a zebrafish model (PMID: 30215711). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally approved by the ClinGen Congenital Myopathies Working Group on 4/13/20 (SOP Version 7). It was reevaluated on 02/21/2025. As a result of this reevaluation no new evidence was identified and the classification remained at Limited.
Inheritance Pattern: AR
Disease ID:MONDO:0034109
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_079420.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 5 | ||||
| missense | 24 | 2 | 1 | 27 | ||
| nonsense | 1 | 1 | ||||
| start loss | 1 | 2 | 3 | |||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 1 | 25 | 9 | 5 | 40 |
Highest pathogenic variant AF is 0.000010533464
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_524144.1 | 6 | MANE Select | |
| Ensembl | ENSP00000307280.4 | 6 | MANE Select | |
| RefSeq | NP_524146.1 | 6 | Standard | |
| Ensembl | ENSP00000343321.4 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Endothelin Pathways
- Association Between Physico-Chemical Features and Toxicity Associated Pathways
- Striated Muscle Contraction
- Regulation of Actin Cytoskeleton
- G13 Signaling Pathway
Biological Process
- muscle contraction
- muscle filament sliding
- cardiac muscle contraction
Molecular Function
- calcium ion binding
- structural constituent of muscle
Cellular Component
- cytosol
- muscle myosin complex
- myofibril
- sarcomere
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000352451
- Coding exons
- 6
- Length
- 25041
- Individuals with no LoFs
- 125732
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 16
- Defined
- 125748
- p
- 0.0000636
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.523 | 95 | 110 | 0.860 | 0.00000572 | 1284 |
| Missense (PolyPhen) | 41 | 35.422 | 1.1575 | 429 | ||
| Synonymous | -0.504 | 45 | 40.9 | 1.10 | 0.00000237 | 370 |
| Loss of Function | 0.791 | 7 | 9.65 | 0.725 | 4.72e-7 | 117 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0.00031 | 0.00029 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulatory light chain of myosin. Does not bind calcium.;
Intolerance Scores
- LoFtool
- 0.278
- RVIS EVS
- -0.05
- RVIS percentile EVS
- 50.01
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.307
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |